Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 May 4;375(6526):64-8.
doi: 10.1038/375064a0.

Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone

Affiliations

Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone

Y Lunardi-Iskandar et al. Nature. .

Erratum in

  • Nature 1995 Aug 3;376(6539):447

Abstract

Kaposi's sarcoma (KS) occurs more often in men than in women and HIV-1-associated KS has a high occurrence in homosexual men (over 30%). Most cultures of KS tumours yield cells with properties of hyperplastic (not malignant) endothelial cells under the control of several cytokines. The role of HIV-1 may be in promoting high levels of some cytokines and providing stimulation to angiogenesis by the HIV-1 Tat protein, which synergizes with basic fibroblast growth factor in promoting these effects. Here we describe an immortalized AIDS-KS cell line (KS Y-1) and show that these cells produce malignant metastatic tumours in nude mice and are killed in vitro and in vivo (apparently by apoptosis) by a pregnancy hormone, the beta-chain of human chorionic gonadotropin. Similarly, chorionic gonadotropin kills KS SLK, cells from another neoplastic cell line (established from a non-HIV-associated KS), as well as the hyperplastic KS cells from clinical specimens grown in short-term culture, but does not kill normal endothelial cells. These results provide evidence that KS can evolve into a malignancy and have implications for the hormonal treatment of this tumour.

PubMed Disclaimer

Comment in

  • Kaposi's sarcoma in pregnant women.
    Rabkin CS, Chibwe G, Muyunda K, Musaba E. Rabkin CS, et al. Nature. 1995 Sep 7;377(6544):21; author reply 22. doi: 10.1038/377021a0. Nature. 1995. PMID: 7659154 No abstract available.
  • Kaposi's sarcoma in pregnant women.
    Berger P, Dirnhofer S. Berger P, et al. Nature. 1995 Sep 7;377(6544):21-2. doi: 10.1038/377021b0. Nature. 1995. PMID: 7659155 No abstract available.

Substances